Document is current
Any future updates will be listed below
-
Authors
Martínez-Sanz, Javier
Muriel, Alfonso
Vivancos-Gallego, María Jesús
Galán, Juan Carlos
Romero, Beatriz
Rodríguez-Sagrado, Miguel Ángel
Uranga, Almudena
Pérez-Elías, Pilar
Barea, Rafael
Chamorro-Escobar, Clotilde
Herrero-Delgado, Margarita
Pérez-Elías, María Jesús
-
Funding
Funding for this research was provided by:
Merck Sharp and Dohme
Roche
Janssen Biotech
Abbott Laboratories
Pfizer
Bristol-Myers Squibb
ViiV Healthcare
European Regional Development Fund (RD16/0025/0001)
Boehringer Ingelheim
Instituto de Salud Carlos III
Gilead Sciences
Instituto de Salud Carlos III
Ministerio de Sanidad, Servicios Sociales e Igualdad (EC11-144)
Instituto de Salud Carlos III (PI16/00551, PI12-00995)
GlaxoSmithKline
- License Information
-
More Information
This article is maintained by: Elsevier
Article Title: Prevalence of HCV infection in a health area of Madrid (Spain): the first step towards microelimination
Journal Title: Enfermedades infecciosas y microbiologia clinica (English ed.)
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.eimce.2019.10.012
CrossRef DOI link to the associated document: https://doi.org/10.1016/j.eimc.2019.10.014
Content Type: article
Copyright: © 2019 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. All rights reserved.
